ATE189819T1 - Abtrennung von nichtmodifiziertem hämoglobin aus vernetztem hämoglobin - Google Patents

Abtrennung von nichtmodifiziertem hämoglobin aus vernetztem hämoglobin

Info

Publication number
ATE189819T1
ATE189819T1 AT96918239T AT96918239T ATE189819T1 AT E189819 T1 ATE189819 T1 AT E189819T1 AT 96918239 T AT96918239 T AT 96918239T AT 96918239 T AT96918239 T AT 96918239T AT E189819 T1 ATE189819 T1 AT E189819T1
Authority
AT
Austria
Prior art keywords
hemoglobin
cross
unmodified
linked
separation
Prior art date
Application number
AT96918239T
Other languages
English (en)
Inventor
William R Light
Maria S Gawryl
Anthony J Laccetti
Robert A Houtchens
Original Assignee
Biopure Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopure Corp filed Critical Biopure Corp
Application granted granted Critical
Publication of ATE189819T1 publication Critical patent/ATE189819T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT96918239T 1995-06-07 1996-06-05 Abtrennung von nichtmodifiziertem hämoglobin aus vernetztem hämoglobin ATE189819T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/477,916 US5952470A (en) 1995-06-07 1995-06-07 Method for separating unmodified hemoglobin from cross-linked hemoglobin
PCT/US1996/009251 WO1996040783A1 (en) 1995-06-07 1996-06-05 Separating unmodified hemoglobin from cross-linked hemoglobin

Publications (1)

Publication Number Publication Date
ATE189819T1 true ATE189819T1 (de) 2000-03-15

Family

ID=23897852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918239T ATE189819T1 (de) 1995-06-07 1996-06-05 Abtrennung von nichtmodifiziertem hämoglobin aus vernetztem hämoglobin

Country Status (9)

Country Link
US (3) US5952470A (de)
EP (1) EP0832131B1 (de)
JP (1) JP3950477B2 (de)
AT (1) ATE189819T1 (de)
AU (1) AU6094396A (de)
CA (1) CA2222679C (de)
DE (1) DE69606707T2 (de)
ES (1) ES2142590T3 (de)
WO (1) WO1996040783A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952470A (en) * 1995-06-07 1999-09-14 Biopure Corporation Method for separating unmodified hemoglobin from cross-linked hemoglobin
US6500809B1 (en) 1999-11-12 2002-12-31 Neuron Therapeutics, Inc. Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
WO2001076507A2 (en) 2000-04-11 2001-10-18 The University Of Miami Use of oxygen carriers to improve grafted cell survival in neural transplantation
US20030079015A1 (en) * 2001-05-09 2003-04-24 Dotclick Corporation Method, apparatus and program product providing business processes using media identification and tracking of associated user preferences
EP1865993A2 (de) * 2005-04-05 2007-12-19 Biopure Corporation Sauerstoffangereicherte, polymerisierte hämoglobinlösungen und ihre verwendung zur sichtbarmachung von gewebe
US20090117207A1 (en) * 2005-11-29 2009-05-07 Zoltani Csaba K Methods and compositions for treatment of poison-caused pathology
US20080118572A1 (en) * 2006-10-10 2008-05-22 Harold Richard Hellstrom Methods and compositions for reducing the risk of adverse cardiovascular events associated with the administration of artificial blood
US20110319332A1 (en) * 2010-06-23 2011-12-29 Bing Lou Wong Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) * 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US11504417B2 (en) 2017-07-18 2022-11-22 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making
WO2021034416A2 (en) 2019-07-02 2021-02-25 Hbo2 Therapeutics, Llc Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34271A (en) * 1862-01-28 Improvement in shuttles
US32089A (en) * 1861-04-16 Carpet-fastener
USRE32089E (en) 1970-08-25 1986-03-04 Amicon Corporation Blood fractionating process and apparatus for carrying out same
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3858014A (en) * 1973-10-19 1974-12-31 G Hughes Gauge and switch diaphragm protector
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4136093A (en) * 1976-04-23 1979-01-23 Biotest-Serum-Institut Gmbh Hemoglobin preparation with increased oxygen release
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
US4604348A (en) * 1981-11-19 1986-08-05 New York Blood Center, Inc. Composition for use in immunoassays
USRE34271E (en) 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US5194590A (en) * 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5084558A (en) * 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
CA1312009C (en) * 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
DE3778006D1 (de) * 1986-11-10 1992-05-07 Biopure Corp Hochreines, halbsynthetisches blutsurrogat.
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
US4980058A (en) * 1987-11-06 1990-12-25 Bio-Rad Laboratories, Inc. Separation of hemoglobin A2 from hemoglobin mixture
US5051353A (en) * 1988-08-09 1991-09-24 The United States Of America As Represented By The Secretary Of The Navy Preservation and restoration of hemoglobin in blood substitutes
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
US5250665A (en) * 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation
ES2095751T3 (es) * 1993-03-16 1997-02-16 Hemosol Inc Regulacion selectiva de hemoglobinas mediante sacaridos de anillo abierto oxidados.
US5952470A (en) * 1995-06-07 1999-09-14 Biopure Corporation Method for separating unmodified hemoglobin from cross-linked hemoglobin

Also Published As

Publication number Publication date
AU6094396A (en) 1996-12-30
CA2222679C (en) 2010-08-17
DE69606707T2 (de) 2000-11-16
WO1996040783A1 (en) 1996-12-19
CA2222679A1 (en) 1996-12-19
US20030203350A1 (en) 2003-10-30
JP3950477B2 (ja) 2007-08-01
US5952470A (en) 1999-09-14
DE69606707D1 (de) 2000-03-23
US20050143565A1 (en) 2005-06-30
ES2142590T3 (es) 2000-04-16
EP0832131A1 (de) 1998-04-01
JPH11507336A (ja) 1999-06-29
EP0832131B1 (de) 2000-02-16

Similar Documents

Publication Publication Date Title
ATE189819T1 (de) Abtrennung von nichtmodifiziertem hämoglobin aus vernetztem hämoglobin
EA199900540A1 (ru) Усовершенствованный способ извлечения олефинов из крекинг-газов с использованием процесса химической абсорбции
ES2155477T3 (es) Purificacion cromatografica y procedimiento de separacion de acidos nucleicos.
ATE34177T1 (de) Verfahren zur gewinnung einer peptidbindungen enthaltenden verbindung.
NO995428L (no) Fremgangsmåte for å separere ut hydrokarbongassbestanddeler
AU642403B2 (en) Method for the use and synthesis of peptides
DE69524092D1 (de) Fraktionierungsverfahren für saccharose enthaltende lösungen
FI932150A0 (fi) Analyssystem foer glykerande blodproteiner
AU7067687A (en) Process for separating hydrocarbon gas constituents
DE69003362D1 (de) Spaltverfahren für Lagerungsteile durch Wasserstoffeintrag.
ATE79633T1 (de) Verfahren zur herstellung des alpha-1-proteinase- inhibitors.
DE59912722D1 (de) Kontinuierliches verfahren zur trennung von stoffen nach molekülgrösse
ATE154033T1 (de) Verfahren zur reinigung von proteinen
MY106946A (en) Process for recycling and purifying condensate from a hydrocarbon or alcohol synthesis process.
KR850000255A (ko) 혼합가스의 분리방법 및 그 장치
EP1240200A4 (de) Abtrennung von fibrinogen von plasmaproteasen
EP0333474A3 (de) Verfahren zur selektiven Entfernung von Endotoxin
DE60104445D1 (de) Verfahren zur fraktionierung flüssiger mischungen
DE3852575D1 (de) Trennung von Flüssigkeitsgemischen.
DE69006489D1 (de) Verfahren zur kontinuierlichen wiedergewinnung von fluorwasserstoffgas.
PT816377E (pt) Peptideos que se ligam a protrombina e a trombina
DE3878900D1 (de) Vorrichtung zur gewinnung von kohlenwasserstoffen aus hochkonzentrierten gasstroemen.
AU1810999A (en) Dehydrocyclization process with downstream dimethylbutane removal
BG97981A (en) Method for separation of two hard components
FI943467A0 (fi) Menetelmä bakteeriperäisten lipopolysakkaridien erottamiseksi proteiinipitoisista liuoksista

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties